Published in
NEJM Evidence, 1(1), 2022
Links
Tools
Zilovertamab Vedotin Targeting of ROR1 as Therapy for Lymphoid Cancers
Journal article published in 2022 by
Michael L. Wang,
Jacqueline C. Barrientos,
Richard R. Furman,
Matthew Mei,
Paul M. Barr 
,
Michael Y. Choi,
Sven de Vos,
Avyakta Kallam,
Krish Patel ,
Thomas J. Kipps,
Simon Rule,
Kate Flanders,
Katti A. Jessen,
Hong Ren,
Peter C. Riebling
and other authors.
,
Michael Y. Choi,
Sven de Vos,
Avyakta Kallam,
Krish Patel ,
Thomas J. Kipps,
Simon Rule,
Kate Flanders,
Katti A. Jessen,
Hong Ren,
Peter C. Riebling
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Data provided by 